|
FY2021
12 months to Jan 31, 2021
|
FY2020
12 months to Jan 31, 2020
|
FY2019
12 months to Jan 31, 2019
|
FY2018
12 months to Jan 31, 2018
|
|
|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||
| Depreciation and amortization | ||||
| Non-cash lease expense | ||||
| Impairment of real estate lease related assets | ||||
| Stock-based compensation expense | ||||
| Donation of common stock to the Cloudera Foundation | ||||
| Accretion and amortization of marketable securities | ||||
| Amortization of deferred contract costs | ||||
| Loss (gain) on disposal of fixed assets | ||||
| Release of deferred tax valuation allowance | ||||
| Other | ||||
| Changes in assets and liabilities: | ||||
| Accounts receivable | ||||
| Contract assets | ||||
| Prepaid expenses and other assets | ||||
| Deferred contract costs | ||||
| Accounts payable | ||||
| Accrued compensation | ||||
| Other accrued liabilities | ||||
| Operating lease liabilities | ||||
| Other contract liabilities | ||||
| Other | ||||
| Deferred Revenue | ||||
| Total other contract liabilities | ||||
| Net cash provided by (used in) operating activities | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||
| Purchases of marketable securities | ||||
| Proceeds from sale of marketable securities | ||||
| Maturities of marketable securities | ||||
| Cash used in business combinations, net of cash acquired | ||||
| Cash acquired in a business combination | ||||
| Capital expenditures | ||||
| Proceeds from sale of equipment | ||||
| Net cash (used in) provided by investing activities | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||
| Net proceeds from issuance of common stock in initial public offering | ||||
| Net proceeds from issuance of common stock in follow-on offering | ||||
| Proceeds from debt, net of issuance costs | ||||
| Repurchases of common stock | ||||
| Taxes paid related to net share settlement of equity awards | ||||
| Proceeds from employee stock plans | ||||
| Net cash provided by (used in) financing activities | ||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | ||||
| Cash, cash equivalents and restricted cash — Beginning of period | ||||
| Cash, cash equivalents and restricted cash — End of period | ||||
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | ||||
| Cash paid for income taxes | ||||
| Purchases of property and equipment, accrued but not yet paid | ||||
| Fair value of common stock issued as consideration for a business combination | ||||
| Offering costs in accounts payable and other accrued liabilities | ||||
| Conversion of redeemable convertible preferred stock to common stock | ||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | ||||
| Reconciliation of cash, cash equivalents and restricted cash as shown in the statement of cash flows | ||||
| Cash and cash equivalents | ||||
| Restricted cash included in Other assets | ||||
Loading...